Dynavax Technologies (LTS:0IDA) Other Long-Term Liabilities : $60.5 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dynavax Technologies Other Long-Term Liabilities?

Dynavax Technologies's other long-term liabilities for the quarter that ended in Mar. 2024 was $60.5 Mil.

Dynavax Technologies's quarterly other long-term liabilities declined from Sep. 2023 ($60.7 Mil) to Dec. 2023 ($60.4 Mil) but then increased from Dec. 2023 ($60.4 Mil) to Mar. 2024 ($60.5 Mil).

Dynavax Technologies's annual other long-term liabilities declined from Dec. 2021 ($5.7 Mil) to Dec. 2022 ($0.4 Mil) but then increased from Dec. 2022 ($0.4 Mil) to Dec. 2023 ($60.4 Mil).

Dynavax Technologies Other Long-Term Liabilities Historical Data

The historical data trend for Dynavax Technologies's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Other Long-Term Liabilities Chart

Dynavax Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Dynavax Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Dynavax Technologies Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Dynavax Technologies Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Dynavax Technologies's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynavax Technologies (LTS:0IDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (LTS:0IDA) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

DVAX:USA DYF1:Germany

Address

2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608

Website

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies (LTS:0IDA) Headlines

No Headlines